|
|
|
|
|||||
|
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost  |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | May 01 '25 | Option Exercise | 6.32 | 68,412 | 432,364 | 1,347,936 | May 05 05:27 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | May 01 '25 | Sale | 7.35 | 68,412 | 502,828 | 1,279,524 | May 05 05:27 PM |
| ADPT | Harlan Robins | Officer | May 01 '25 | Proposed Sale | 7.36 | 68,412 | 503,512 | May 01 05:38 PM | |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Mar 24 '25 | Option Exercise | 6.32 | 1,698 | 10,731 | 1,281,222 | Mar 26 06:48 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Mar 24 '25 | Sale | 9.00 | 1,698 | 15,282 | 1,279,524 | Mar 26 06:48 PM |
| ADPT | Harlan Robins | Officer | Mar 24 '25 | Proposed Sale | 8.66 | 1,698 | 14,705 | Mar 24 05:45 PM | |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Mar 05 '25 | Sale | 6.99 | 96,656 | 675,219 | 1,279,524 | Mar 06 07:18 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Mar 07 '22 | Sale | 12.01 | 4,517 | 54,249 | 311,960 | Mar 08 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Nov 17 '21 | Option Exercise | 6.55 | 3,700 | 24,235 | 73,060 | Nov 19 04:59 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Nov 18 '21 | Option Exercise | 6.55 | 300 | 1,965 | 69,660 | Nov 19 04:59 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Nov 18 '21 | Sale | 31.36 | 300 | 9,408 | 69,360 | Nov 19 04:59 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Nov 17 '21 | Sale | 32.05 | 3,700 | 118,585 | 69,360 | Nov 19 04:59 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 19 '21 | Option Exercise | 6.55 | 3,800 | 24,890 | 73,160 | Oct 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 20 '21 | Option Exercise | 6.55 | 3,700 | 24,235 | 73,060 | Oct 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 21 '21 | Option Exercise | 6.55 | 3,700 | 24,235 | 73,060 | Oct 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 21 '21 | Sale | 33.73 | 3,700 | 124,801 | 69,360 | Oct 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 20 '21 | Sale | 33.71 | 3,700 | 124,727 | 69,360 | Oct 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 19 '21 | Sale | 33.69 | 3,800 | 128,033 | 69,360 | Oct 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 06 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | Oct 08 07:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 08 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | Oct 08 07:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 07 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | Oct 08 07:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 07 '21 | Sale | 33.62 | 3,895 | 130,948 | 69,360 | Oct 08 07:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 08 '21 | Sale | 32.96 | 3,895 | 128,379 | 69,360 | Oct 08 07:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 06 '21 | Sale | 32.27 | 3,895 | 125,692 | 69,360 | Oct 08 07:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sep 13 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | Sep 15 07:51 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sep 14 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | Sep 15 07:51 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sep 15 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | Sep 15 07:51 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sep 15 '21 | Sale | 36.68 | 3,895 | 142,884 | 69,360 | Sep 15 07:51 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sep 14 '21 | Sale | 36.74 | 3,895 | 143,086 | 69,360 | Sep 15 07:51 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sep 13 '21 | Sale | 37.51 | 3,895 | 146,084 | 69,360 | Sep 15 07:51 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Aug 25 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | Aug 27 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Aug 26 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | Aug 27 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Aug 27 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | Aug 27 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Aug 27 '21 | Sale | 34.78 | 3,895 | 135,449 | 69,360 | Aug 27 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Aug 26 '21 | Sale | 33.89 | 3,895 | 132,002 | 69,360 | Aug 27 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Aug 25 '21 | Sale | 34.09 | 3,895 | 132,781 | 69,360 | Aug 27 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jul 19 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | Jul 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jul 20 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | Jul 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jul 21 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | Jul 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jul 21 '21 | Sale | 37.82 | 3,895 | 147,290 | 69,360 | Jul 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jul 20 '21 | Sale | 37.48 | 3,895 | 145,996 | 69,360 | Jul 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jul 19 '21 | Sale | 37.12 | 3,895 | 144,598 | 69,360 | Jul 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jun 09 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | Jun 11 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jun 10 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | Jun 11 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jun 11 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | Jun 11 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jun 11 '21 | Sale | 38.41 | 3,895 | 149,607 | 69,360 | Jun 11 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jun 10 '21 | Sale | 37.56 | 3,895 | 146,294 | 69,360 | Jun 11 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jun 09 '21 | Sale | 35.99 | 3,895 | 140,164 | 69,360 | Jun 11 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | May 05 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | May 07 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | May 06 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | May 07 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | May 06 '21 | Sale | 35.70 | 3,895 | 139,048 | 69,360 | May 07 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | May 05 '21 | Sale | 35.43 | 3,195 | 113,199 | 69,360 | May 07 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | May 04 '21 | Option Exercise | 6.32 | 3,895 | 24,616 | 73,255 | May 06 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | May 04 '21 | Sale | 36.14 | 3,895 | 140,748 | 69,360 | May 06 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Apr 20 '21 | Option Exercise | 6.32 | 11,685 | 73,849 | 81,045 | Apr 22 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Apr 21 '21 | Option Exercise | 6.32 | 7,790 | 49,233 | 77,150 | Apr 22 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Apr 22 '21 | Option Exercise | 6.32 | 7,790 | 49,233 | 77,150 | Apr 22 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Apr 22 '21 | Sale | 43.18 | 7,790 | 336,399 | 69,360 | Apr 22 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Apr 21 '21 | Sale | 41.50 | 7,790 | 323,278 | 69,360 | Apr 22 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Apr 20 '21 | Sale | 40.52 | 11,685 | 473,534 | 69,360 | Apr 22 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Mar 23 '21 | Option Exercise | 6.32 | 7,790 | 49,233 | 77,150 | Mar 25 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Mar 25 '21 | Option Exercise | 6.32 | 5,290 | 33,433 | 74,650 | Mar 25 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Mar 24 '21 | Option Exercise | 6.32 | 6,395 | 40,416 | 75,755 | Mar 25 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Mar 24 '21 | Sale | 40.16 | 6,395 | 256,844 | 69,360 | Mar 25 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Mar 25 '21 | Sale | 38.30 | 5,290 | 202,581 | 69,360 | Mar 25 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Mar 23 '21 | Sale | 41.93 | 7,790 | 326,635 | 69,360 | Mar 25 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Feb 03 '21 | Option Exercise | 6.32 | 7,790 | 49,233 | 8,469 | Feb 05 06:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Feb 03 '21 | Sale | 59.58 | 7,790 | 464,158 | 679 | Feb 05 06:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Feb 01 '21 | Option Exercise | 6.32 | 7,790 | 49,233 | 8,469 | Feb 03 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Feb 02 '21 | Option Exercise | 6.32 | 7,790 | 49,233 | 8,469 | Feb 03 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Feb 02 '21 | Sale | 59.65 | 7,790 | 464,647 | 679 | Feb 03 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Feb 01 '21 | Sale | 55.83 | 7,790 | 434,954 | 679 | Feb 03 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jan 21 '21 | Option Exercise | 6.32 | 23,370 | 147,698 | 24,049 | Jan 25 07:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jan 21 '21 | Sale | 66.82 | 23,370 | 1,561,592 | 679 | Jan 25 07:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jan 19 '21 | Option Exercise | 6.32 | 50,000 | 316,000 | 50,679 | Jan 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jan 20 '21 | Option Exercise | 6.32 | 50,000 | 316,000 | 50,679 | Jan 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jan 20 '21 | Sale | 67.24 | 50,000 | 3,362,059 | 679 | Jan 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jan 19 '21 | Sale | 67.95 | 50,000 | 3,397,517 | 679 | Jan 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Nov 05 '20 | Option Exercise | 6.32 | 11,100 | 70,152 | 11,779 | Nov 06 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Nov 06 '20 | Option Exercise | 6.32 | 11,100 | 70,152 | 11,779 | Nov 06 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Nov 04 '20 | Option Exercise | 6.32 | 11,100 | 70,152 | 11,779 | Nov 06 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Nov 04 '20 | Sale | 50.29 | 11,100 | 558,234 | 679 | Nov 06 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Nov 06 '20 | Sale | 51.50 | 11,100 | 571,629 | 679 | Nov 06 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Nov 05 '20 | Sale | 50.30 | 11,100 | 558,384 | 679 | Nov 06 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 16 '20 | Option Exercise | 6.32 | 11,100 | 70,152 | 11,779 | Oct 20 07:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 16 '20 | Sale | 51.79 | 11,100 | 574,869 | 679 | Oct 20 07:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 14 '20 | Option Exercise | 6.32 | 11,100 | 70,152 | 11,779 | Oct 16 05:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 15 '20 | Option Exercise | 6.32 | 11,100 | 70,152 | 11,779 | Oct 16 05:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 15 '20 | Sale | 51.55 | 11,100 | 572,205 | 679 | Oct 16 05:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Oct 14 '20 | Sale | 52.17 | 11,100 | 579,133 | 679 | Oct 16 05:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sep 22 '20 | Option Exercise | 6.32 | 11,100 | 70,152 | 11,779 | Sep 24 08:24 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sep 23 '20 | Option Exercise | 6.32 | 11,100 | 70,152 | 11,779 | Sep 24 08:24 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sep 24 '20 | Option Exercise | 6.32 | 11,100 | 70,152 | 11,779 | Sep 24 08:24 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sep 24 '20 | Sale | 47.11 | 11,100 | 522,879 | 679 | Sep 24 08:24 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sep 23 '20 | Sale | 48.16 | 11,100 | 534,576 | 679 | Sep 24 08:24 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Sep 22 '20 | Sale | 47.57 | 11,100 | 527,975 | 679 | Sep 24 08:24 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Aug 21 '20 | Option Exercise | 6.32 | 11,100 | 70,152 | 11,779 | Aug 24 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Aug 19 '20 | Option Exercise | 6.32 | 11,100 | 70,152 | 11,779 | Aug 24 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Aug 20 '20 | Option Exercise | 6.32 | 11,100 | 70,152 | 11,779 | Aug 24 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Aug 20 '20 | Sale | 42.93 | 11,100 | 476,527 | 679 | Aug 24 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Aug 19 '20 | Sale | 42.48 | 11,100 | 471,513 | 679 | Aug 24 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Aug 21 '20 | Sale | 43.12 | 11,100 | 478,658 | 679 | Aug 24 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jul 16 '20 | Option Exercise | 6.32 | 22,200 | 140,304 | 22,879 | Jul 17 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jul 17 '20 | Option Exercise | 6.32 | 11,100 | 70,152 | 11,779 | Jul 17 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jul 17 '20 | Sale | 39.60 | 11,100 | 439,611 | 679 | Jul 17 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jul 16 '20 | Sale | 39.57 | 22,200 | 878,369 | 679 | Jul 17 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jun 23 '20 | Option Exercise | 6.32 | 11,100 | 70,152 | 11,779 | Jun 25 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jun 24 '20 | Option Exercise | 6.32 | 11,100 | 70,152 | 11,779 | Jun 25 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jun 25 '20 | Option Exercise | 6.32 | 11,100 | 70,152 | 11,779 | Jun 25 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jun 25 '20 | Sale | 46.88 | 11,100 | 520,423 | 679 | Jun 25 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jun 24 '20 | Sale | 45.89 | 11,100 | 509,355 | 679 | Jun 25 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jun 23 '20 | Sale | 46.85 | 11,100 | 520,035 | 679 | Jun 25 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | May 19 '20 | Sale | 40.11 | 38,628 | 1,549,369 | 32,051 | May 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | May 20 '20 | Sale | 40.48 | 31,372 | 1,269,939 | 679 | May 21 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | May 14 '20 | Option Exercise | 6.32 | 31,200 | 197,184 | 101,879 | May 18 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | May 15 '20 | Option Exercise | 6.32 | 35,400 | 223,728 | 106,079 | May 18 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | May 18 '20 | Option Exercise | 6.32 | 11,100 | 70,152 | 81,779 | May 18 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | May 18 '20 | Sale | 39.32 | 11,100 | 436,482 | 70,679 | May 18 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | May 15 '20 | Sale | 37.43 | 35,400 | 1,324,931 | 70,679 | May 18 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | May 14 '20 | Sale | 35.32 | 31,200 | 1,101,952 | 70,679 | May 18 09:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Apr 20 '20 | Option Exercise | 6.32 | 14,900 | 94,168 | 85,579 | Apr 22 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Apr 21 '20 | Option Exercise | 6.32 | 3,900 | 24,648 | 74,579 | Apr 22 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Apr 22 '20 | Option Exercise | 6.32 | 25,600 | 161,792 | 96,279 | Apr 22 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Apr 22 '20 | Sale | 30.28 | 25,600 | 775,103 | 70,679 | Apr 22 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Apr 21 '20 | Sale | 29.21 | 3,900 | 113,907 | 70,679 | Apr 22 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Apr 20 '20 | Sale | 28.83 | 14,900 | 429,506 | 70,679 | Apr 22 08:00 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Feb 20 '20 | Option Exercise | 6.32 | 7,400 | 46,768 | 78,079 | Feb 24 04:15 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Feb 20 '20 | Sale | 33.46 | 7,400 | 247,578 | 70,679 | Feb 24 04:15 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Feb 18 '20 | Option Exercise | 6.32 | 18,500 | 116,920 | 89,179 | Feb 20 04:30 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Feb 19 '20 | Option Exercise | 6.32 | 7,400 | 46,768 | 78,079 | Feb 20 04:30 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Feb 19 '20 | Sale | 32.72 | 7,400 | 242,149 | 70,679 | Feb 20 04:30 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Feb 18 '20 | Sale | 31.38 | 18,500 | 580,530 | 70,679 | Feb 20 04:30 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jan 17 '20 | Option Exercise | 6.32 | 3,700 | 23,384 | 74,379 | Jan 17 05:29 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jan 15 '20 | Option Exercise | 6.32 | 3,700 | 23,384 | 74,379 | Jan 17 05:29 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jan 16 '20 | Option Exercise | 6.32 | 3,700 | 23,384 | 74,379 | Jan 17 05:29 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jan 16 '20 | Sale | 28.83 | 3,700 | 106,656 | 70,679 | Jan 17 05:29 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jan 15 '20 | Sale | 29.52 | 3,700 | 109,224 | 70,679 | Jan 17 05:29 PM |
| ADPT | ROBINS HARLAN S | Chief Scientific Officer | Jan 17 '20 | Sale | 27.96 | 3,700 | 103,449 | 70,679 | Jan 17 05:29 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite